Bellicum Pharmaceuticals Q3 EPS $(0.68) Misses $(0.53) Estimate

Bellicum Pharmaceuticals (NASDAQ:BLCM) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.53) by 28.3 percent. This is a 23.64 percent decrease over losses of $(0.55) per

Benzinga · 11/06/2019 22:13

Bellicum Pharmaceuticals (NASDAQ:BLCM) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.53) by 28.3 percent. This is a 23.64 percent decrease over losses of $(0.55) per share from the same period last year.